We are a late-stage biopharmaceutical company focused on the development and commercialization of nov
Location: United States, Texas, Dallas
Employees: 11-50
Phone: +1 214-442-8100
Total raised: $24M
Founded date: 2003
Investors 1
| Date | Name | Website |
| - | WP Global ... | wpglobalpa... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.01.2013 | Series B | $24M | - |
Mentions in press and media 3
| Date | Title | Description |
| 16.11.2023 | Gradalis Awarded $9.9 Million Grant From the Cancer Prevention and Research Institute of Texas | - |
| 03.01.2013 | Gradalis Raises $24M in Series B Financing | Gradalis, a Dallas, Texas-basedbiotechnology company, has raised $24m in Series B financing. Backers were not disclosed. Led by David Shanahan, president, CEO and co-founder, Gradalis focuses on developing, manufacturing and commercializing... |
| 03.01.2013 | Gradalis Closes $24M in Series B | DALLAS, TX, Gradalis, Inc. today announced that is has closed a $24 million Series B round of financing. Gradalis will use the funding to advance its autologous vaccine platform. >> Click here for more funding data on Gradalis >... |